Patients with deaths from COVID-19 often have co-morbid cardiovascular disease. Real-time cardiovascular disease monitoring based on wearable medical devices may effectively reduce COVID-19 mortality rates. However, due to technical limitations, there are three main issues. First, the traditional wireless communication technology for wearable medical devices is difficult to satisfy the real-time requirements fully. Second, current monitoring platforms lack efficient streaming data processing mechanisms to cope with the large amount of cardiovascular data generated in real time. Third, the diagnosis of the monitoring platform is usually manual, which is challenging to ensure that enough doctors online to provide a timely, efficient, and accurate diagnosis. To address these issues, this paper proposes a 5G-enabled real-time cardiovascular monitoring system for COVID-19 patients using deep learning. Firstly, we employ 5G to send and receive data from wearable medical devices. Secondly, Flink streaming data processing framework is applied to access electrocardiogram data. Finally, we use convolutional neural networks and long short-term memory networks model to obtain automatically predict the COVID-19 patient's cardiovascular health. Theoretical analysis and experimental results show that our proposal can well solve the above issues and improve the prediction accuracy of cardiovascular disease to 99.29%.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255093 | PMC |
http://dx.doi.org/10.1007/s00521-021-06219-9 | DOI Listing |
Nat Commun
December 2024
Neuroengineering Laboratory, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.
Peripheral neuropathy (PN), the most common complication of diabetes, leads to sensory loss and associated health issues as pain and increased fall risk. However, present treatments do not counteract sensory loss, but only partially manage its consequences. Electrical neural stimulation holds promise to restore sensations, but its efficacy and benefits in PN damaged nerves are yet unknown.
View Article and Find Full Text PDFFront Artif Intell
December 2024
Hospital and Rehabilitation Centre for the Disabled Children (HRDC), Banepa, Nepal.
Introduction: The convergence of healthcare with the Internet of Things (IoT) and Artificial Intelligence (AI) is reshaping medical practice with promising enhanced data-driven insights, automated decision-making, and remote patient monitoring. It has the transformative potential of these technologies to revolutionize diagnosis, treatment, and patient care.
Purpose: This study aims to explore the integration of IoT and AI in healthcare, outlining their applications, benefits, challenges, and potential risks.
Exp Gerontol
December 2024
Department of Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China. Electronic address:
Frailty is one of the most concerning aspects of global population aging, and early identification is crucial to prevent or reverse its progression. Simple, universal, and efficient frailty assessment technologies are essential for the timely detection of frailty in older patients. Various multi-dimensional assessment instruments have been developed to quantify frailty phenotypes; we review the literature on wearable sensor technologies leveraged for older person frailty assessment.
View Article and Find Full Text PDFSci Rep
December 2024
Center for Surgical Innovation and Engineering, Cedars Sinai Health System, Los Angeles, 90048, USA.
Mechanical failure of medical implants, especially in orthopedic poses a significant burden to the patients and healthcare system. The majority of the implant failures are diagnosed at very late stages and are of mechanical causes. This makes the diagnosis and screening of implant failure very challenging.
View Article and Find Full Text PDFJ Neural Transm (Vienna)
December 2024
Department of Basic and Clinical Neuroscience, The Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 5 Cutcombe Road, London, SE5 9RX, UK.
Parkinson's disease (PD) is a progressive neurodegenerative disorder marked by both motor and non-motor symptoms that necessitate ongoing clinical evaluation and medication adjustments. Home-based wearable sensor monitoring offers a detailed and continuous record of patient symptoms, potentially enhancing disease management. The EmPark-PKG study aims to evaluate the effectiveness of the Parkinson's KinetoGraph (PKG), a wearable sensor device, in monitoring and tracking the progression of motor symptoms over 12 months in Emirati and non-Emirati PD patients.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!